iSpecimen to Participate in Maxim’s 2022 Virtual Growth Conference on March 28-30, 2022
March 15 2022 - 7:30AM
iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”
or the “Company”), a global, proprietary online
marketplace connecting scientists with healthcare providers to
search for biospecimens needed for medical research, today
announced that Christopher Ianelli, MD, PhD, CEO and President of
iSpecimen, will participate in Maxim Group’s 2022 Virtual Growth
Conference to be held virtually on March 28-30, 2022.
Dr. Ianelli's corporate presentation will be available on-demand
starting Monday, March 28, 2022, at 9:00 a.m. ET for all
registrants of the virtual conference. To attend, please register
here. For more information about the Maxim conference, or to
schedule a one-on-one meeting with iSpecimen’s management, please
contact your appropriate Maxim representative directly, or send an
email to KCSA Strategic Communications
at iSpecimen@kcsa.com.
About iSpecimeniSpecimen (Nasdaq: ISPC) offers
an online marketplace for human biospecimens, connecting scientists
in commercial and non-profit organizations with healthcare
providers that have access to patients and specimens needed for
medical discovery. Proprietary, cloud-based technology enables
scientists to intuitively search for specimens and patients across
a federated partner network of hospitals, labs, biobanks, blood
centers and other healthcare organizations. For more information,
please visit www.ispecimen.com.
For further information, please contact:
Investor ContactKCSA Strategic
CommunicationsAllison SossiSpecimen@kcsa.com
Media ContactKCSA Strategic
CommunicationsCaitlin Kasunich / Raquel ConaiSpecimen@kcsa.com
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Aug 2024 to Sep 2024
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Sep 2023 to Sep 2024